Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial | |
Wang, Qui-Qiang; Wei, Lai; Xie, Qing; Hou, Jinlin; Tang, Hong; Ning, Qin; Cheng, Jun; Nan, Yuemin; Zhang, Lunli; Li, Jun | |
刊名 | HEPATOLOGY |
2017 | |
卷号 | 66 |
ISSN号 | 0270-9139 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3539780 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Wang, Qui-Qiang,Wei, Lai,Xie, Qing,et al. Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial[J]. HEPATOLOGY,2017,66. |
APA | Wang, Qui-Qiang.,Wei, Lai.,Xie, Qing.,Hou, Jinlin.,Tang, Hong.,...&Duan, Zhongping.(2017).Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial.HEPATOLOGY,66. |
MLA | Wang, Qui-Qiang,et al."Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial".HEPATOLOGY 66(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论